Exactly, at the risk of repeating myself, too many investors might overlook the importance of the Singapore approval given its small populace - other mkt commentators agree:
https://www.sidley.com/en/insights/publications/2024/03/singapore-moment-has-come-its-role-as-a-new-global-biotech-hub
"In the realm of biotechnology, Singapore now appears poised – after more than two decades of preparation – to capitalize on a confluence of trends to establish itself as one of the industry’s global biotech “hubs”. "
Its really has been trying to make itself the Silicon Valley of Asian biotech. A good catalyst mkt to be approved in.
Exactly, at the risk of repeating myself, too many investors...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.020(3.23%) |
Mkt cap ! $153.0M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 64.5¢ | 62.0¢ | $200.9K | 319.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1459 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 6981 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |